Fondazione Toscana Gabriele Monasterio

Futó vizsgálatok

• Még nem toboroz

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  NCT07116473· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Toboroz

  Pharmacological optimization in prevention in Heart Failure: A Sex-gap?

  2025-520660-18-00· 4. fázis· Policlinico San Donato S.p.A.· Forrás

• Toboroz

  Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?

  NCT07295522· 4. fázis· IRCCS Policlinico S. Donato· Forrás

• Toboroz

  A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis

  NCT07298044· 4. fázis· Bayer· Forrás

• Toboroz

  A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

  2024-515125-28-00· 2. fázis· Imbria Pharmaceuticals Inc.· Forrás

• Toboroz

  ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

  NCT07218887· 1/2. fázis· Alexion Pharmaceuticals, Inc.· Forrás

• Toboroz

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· 3. fázis· Alnylam Pharmaceuticals· Forrás

• Toboroz

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Toboroz

  MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)

  NCT05974462· 3. fázis· University Hospital, Antwerp· Forrás

• Fut, nem toboroz

  A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

  NCT06260709· 2. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel 18F-labelled Tracer, SYN2, for Positron Emission Tomography in Subjects with Suspected Coronary Artery Disease

  2023-506971-89-00· 3. fázis· Syn2bio S.A.· Forrás

• Fut, nem toboroz

  LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

  NCT05983250· 3. fázis· Tenax Therapeutics, Inc.· Forrás

• Toboroz

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· 3. fázis· Intellia Therapeutics· Forrás

• Toboroz

  Effect of dapagliflozin on the quality of life and exercise capacity of patients with amyloid transthyretin cardiac amyloidosis: a pilot, phase 2b study

  2023-504041-31-00· 2. fázis· Fondazione Toscana Gabriele Monasterio· Forrás

• Fut, nem toboroz

  HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation.

  NCT05636176· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A multi-center phase 3 study of 18F-florbetaben positron emission tomography/computed tomography (PET-CT) to non-invasively diagnose cardiac AL amyloidosis: the PETAL study.

  2024-517942-33-03· 3. fázis· Fondazione Toscana Gabriele Monasterio· Forrás

• Toboroz

  ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

  NCT06324682· University Hospital of Ferrara· Forrás

• Toboroz

  Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  NCT05712200· 3. fázis· Anthos Therapeutics, Inc.· Forrás

• Toboroz

  COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

  NCT05633810· 3. fázis· Montreal Heart Institute· Forrás

• Toboroz

  Italian Anderson Fabry Disease Cardiovascular Registry

  NCT06806813· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Forrás

• Toboroz

  Comparison between single and dual therapy with drugs that inhibits platelet aggregation in patient undergoing the percutaneous left atrial appenDAge closure (ARMYDA-AMULET in which people will be allocated by chance to receive two different options of treatment and which will involves different clinical sites)

  2024-515361-34-00· 4. fázis· Fondazione Toscana Gabriele Monasterio· Forrás

• Toboroz

  MYTHS - MYocarditis THerapy With Steroids

  NCT05150704· 3. fázis· Niguarda Hospital· Forrás

• Meghívásos bevonás

  Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

  NCT04848506· 2/3. fázis· Cytokinetics· Forrás

• Fut, nem toboroz

  CHAMPION-AF Clinical Trial

  NCT04394546· Boston Scientific Corporation· Forrás

• Fut, nem toboroz

  Amplatzer Amulet LAAO vs. NOAC

  NCT04226547· Abbott Medical Devices· Forrás

• Fut, nem toboroz

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· 3. fázis· Actelion· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Amiloidózis7 toboroz
• Szívelégtelenség5 toboroz
• Pitvarfibrilláció3 toboroz
• Hipertrófiás kardiomiopátia2 toboroz
• Myocarditis2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Dilated cardiomyopathy1 toboroz
• Fabry-betegség1 toboroz
• Koszorúér-betegség1 toboroz
• Magas vérnyomás1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Ventricular tachycardia1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

  NCT06664801· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

  NCT06580275· Conformal Medical, Inc· Forrás

• Lezárult

  Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy

  2022-502316-36-00· 4. fázis· Myokardia Inc.· Forrás

• Fut, nem toboroz

  Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT06122779· 2. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis

  2024-517971-19-01· 2. fázis· Fondazione Toscana Gabriele Monasterio· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· 3. fázis· Myokardia Inc.· Forrás

• Lezárult

  A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

  NCT05442047· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure

  NCT04705987· 3. fázis· Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás

• Lezárult

  Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)

  NCT03587064· Associazione Portatori Dispositivi Impiantabili Cardiaci· Forrás

• Leállították

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Boston Scientific Corporation· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Amiloidózis50 munka · 10 vizsgálat
• Hipertrófiás kardiomiopátia19 munka · 5 vizsgálat
• Thalassaemia16 munka · 0 vizsgálat
• Pulmonális artériás hipertónia10 munka · 3 vizsgálat
• Dilated cardiomyopathy9 munka · 1 vizsgálat
• Familiáris hiperkoleszterinémia6 munka · 0 vizsgálat